Osiris Therapeutics Inc. isn't making any promises that it will meet the latest deadline handed down by the Nasdaq Stock Exchange to get current with its financial reporting. A Nasdaq Stock Exchange hearings panel has decided to give the Columbia biotech until March 10 to become current with its financial filings with the U.S.